Consumer wellness company Zydus Wellness Limited, known for brands like Sugar Free and Glucon-D, disclosed a 47% decrease in its net profit for FY26, amounting to Rs 197 crore. Despite this decline, the company experienced a 46.4% surge in consolidated net sales, reaching Rs 3,940 crore. In the March quarter, the company’s consolidated net profit fell by nearly 6% to Rs 162 crore, as per its stock exchange filing.
Consolidated revenue from operations in the same quarter saw a substantial increase of 62.1% to approximately Rs 1,476 crore compared to the previous year. Zydus Wellness attributed the revenue growth to contributions from newly acquired businesses, although profitability was affected by integration-related costs and higher operational expenses. Operating performance remained steady, with EBITDA climbing 34.2% year-on-year to Rs 509 crore during FY26.
The company’s board proposed a final dividend of Rs 1.20 per equity share of face value Rs 2 for the financial year, pending shareholder approval at the annual general meeting set for August 4. Sugar Free, a key brand of the company, maintained its dominance in the sugar substitute category with a market share of 96.1%. Additionally, the brand expanded its offerings with new products like Sugar Free D’lite Choco Spread.
RiteBite Max Protein, the protein snacking brand, witnessed operational expansion and enhanced profitability, achieving nearly double-digit EBITDA margins. This growth was attributed to the introduction of new products such as protein drinks and functional snack bars. Glucon-D, the hydration brand, retained its leadership position in the segment with a 58.9% market share and ventured into performance hydration products.
In skincare, Everyuth maintained strong market positions in scrubs and peel-off masks, while Nycil continued to lead the prickly heat powder category. The company highlighted that its broader nutraceutical and wellness portfolio, including brands like Nutralite and Complan, sustained positive momentum throughout the year, despite earnings being impacted by cost pressures and integration expenses related to acquisitions.
